Medifast, Inc. (MED) Misses Q3 EPS by 1c, Sales Fall Short
Medifast, Inc. (NYSE: MED) reported Q3 EPS of $0.36, $0.01 worse than the analyst estimate of $0.37. Revenue for the quarter came in at $76.1 million versus the consensus estimate of $78.89 million.